...
机译:EZH2调节的DAB2IP是Medulloblastoma肿瘤抑制器和用于存活的阳性标记
Departments of Neurosurgery and Pediatric Oncology/Hematology Cancer Center Amsterdam VU;
Departments of Neurosurgery and Pediatric Oncology/Hematology Cancer Center Amsterdam VU;
Departments of Neurosurgery and Pediatric Oncology/Hematology Cancer Center Amsterdam VU;
Departments of Neurosurgery and Pediatric Oncology/Hematology Cancer Center Amsterdam VU;
Departments of Neurosurgery and Pediatric Oncology/Hematology Cancer Center Amsterdam VU;
Department of Molecular Genetics German Cancer Research Center (DKFZ) Heidelberg Germany;
Institut Curie Laboratoire de Genetique et Biologie des Cancers Paris France;
Department of (Neuro)Pathology Academic Medical Center University of Amsterdam Amsterdam;
Departments of Neurosurgery and Pediatric Oncology/Hematology Cancer Center Amsterdam VU;
Departments of Neurosurgery and Pediatric Oncology/Hematology Cancer Center Amsterdam VU;
Departments of Neurosurgery and Pediatric Oncology/Hematology Cancer Center Amsterdam VU;
机译:EZH2调节的DAB2IP是Medulloblastoma肿瘤抑制器和用于存活的阳性标记
机译:CD74调节脑转移中肿瘤细胞HLA II类肽组的复杂性,是患者生存的积极预后标记
机译:双阳性肿瘤标志物预测米兰标准和儿童-PUGH课程中肝细胞癌患者的早期复发和差的存活
机译:P53肿瘤抑制基因作为埃及血症血症儿童骨髓细胞周期标记的诊断价值
机译:髓母细胞瘤和幕上原始神经外胚层肿瘤候选抑癌基因的分子分析
机译:假定的抑癌基因PTPN13 / PTPL1的表达是乳腺癌总体生存的独立预后标志物
机译:EZH2调节的DAB2IP是髓母细胞瘤肿瘤抑制因子和生存阳性标志物
机译:sIRT3是线粒体肿瘤抑制因子和遗传损失导致小鼠模型的ER / pR阳性乳腺肿瘤连接代谢和致癌线粒体肿瘤抑制因子。调整